Gemici, Yagmur InalkacTasci, Irem2022-03-112022-03-112021Gemici, Y. I., & Tasci, I. (2021). Reversible lesion of the corpus callosum associated with COVID-19: A case report. Neurology Asia, 26(4), 821-824.https://hdl.handle.net/20.500.12899/597Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect the central nervous system and peripheral nervous system. Major central nervous system manifestations of SARS-CoV-2 infection include seizures, meningoencephalitis, ischemic stroke, anosmia, and hypogeusia. The reversible splenial lesion syndrome was first described in 2004. Although reversible splenial lesion syndrome was initially recognized as a benign phenomenon, a second type of reversible splenial lesion syndrome was identified in later years, which has a poorer prognosis and potentially serious sequela. Reversible splenial lesion syndrome can be caused by numerous etiologies including viruses. In this report, we present a rare case of COVID-19 with reversible splenial lesion, who presented with ataxia and dizziness.eninfo:eu-repo/semantics/openAccessCOVİD-19encephalitissplenıum of the corpus callosumArticle10.54029/2021vmw264821824WOS:000741407400025Q4